Ellevest Inc’s ADMA Biologics ADMA Stock Holding History

Ellevest Inc’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-115	Closed	-$446	–	1874
2022 Q4	$446	Buy	+115	New	+$355	﹤0.01%	1633
2021 Q2	–	Sell	-610	Closed	-$1K	–	1251
2021 Q1	$1K	Sell	610 -165	-21%	-$378	﹤0.01%	1119
2020 Q4	$2K	Buy	+775	New	+$1.63K	﹤0.01%	951

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Ellevest Inc's ADMA Position: Q1 2023 in Review

Ellevest Inc sold out of ADMA Biologics (ADMA) in Q1 2023, closing a stake of 115 shares — an estimated $446 sold.

Ellevest Inc first reported a position in ADMA in Q4 2020 and held it in 3 quarters. The position peaked at $2K in Q4 2020. 163 funds tracked by Wall St. Rank hold ADMA as of Q1 2023.

Ellevest Inc reported no remaining ADMA Biologics position as of Q1 2023 after selling out during the quarter.
Ellevest Inc sold 115 ADMA Biologics shares in Q1 2023, an estimated $446.
Ellevest Inc first reported a position in ADMA Biologics in Q4 2020 and held it in 3 quarters.
Ellevest Inc's ADMA Biologics position peaked at $2K in Q4 2020.
163 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.